Johnson & Johnson partners with MD Anderson
Johnson & Johnson signed a three-year agreement under which Johnson & Johnson Innovation LLC and Janssen Biotech Inc. will work with the University of Texas’ MD Anderson Cancer Center’s Moon Shots Program to develop immunology-based oncology therapeutics. The partners will work in undisclosed areas of interest to Janssen.
- R&D (No Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.